Back to Gastroenterology
Gastroenterologyv1955Evidence-Based

Truelove and Witts Severity Index for Ulcerative Colitis

Stratifies severity of ulcerative colitis into mild, moderate, or severe categories based on clinical and laboratory parameters

Clinical Input Parameters

Clinical Assessment
Awaiting Parameters
severity
—Points
Ready to Calculate

Awaiting Clinical Input

Enter the clinical input parameters on the left and click Run Clinical Assessment to evaluate this medical calculator with deterministic clinical scoring.

Open in Web App
Clinical decision support tool for licensed medical practitioners. Confirm independently before prescribing or clinical action.

When & Why to Use

The Truelove and Witts Severity Index for Ulcerative Colitis is utilized in clinical practice for risk stratification, diagnostic probability estimation, and treatment decision-making within gastroenterology.

Use this tool during initial patient intake, emergency department workup, or bedside assessment when objective clinical scoring is required to guide management or admission decisions.

Clinical Formula & Scoring Logic

Classification based on presence of criteria: Mild = all criteria for mild severity met (bowel movements <4, no/small blood, no fever, pulse ≤90, no anemia, ESR ≤30); Severe = ≥6 bowel movements AND ≥1 systemic feature (fever, tachycardia, anemia); Moderate = between mild and severe criteria

Clinical Pearls & Practice Notes

  • The index was originally developed in 1955 as part of the first clinical trial demonstrating effectiveness of cortisone in ulcerative colitis
  • Pyrexia is defined as temperature ≥100.04°F (37.8°C)
  • Anemia is defined as hemoglobin ≤10.5 g/dL (105 g/L)
  • ESR threshold is 30 mm/hr
  • This index is widely used for initial assessment and clinical trials but should be combined with endoscopic findings for comprehensive evaluation
  • Severe classification requires urgent medical attention and possible hospitalization

Evidence & Literature Citations

  1. Truelove SC, Witts LJ. Cortisone in ulcerative colitis; final report on a therapeutic trial. Br Med J. 1955;2(4947):1041-8. PMID: 13260656; PMCID: PMC2061071.
  2. Danese S, Fiocchi C. Ulcerative colitis. N Engl J Med. 2011 Nov 3;365(18):1713-25. doi: 10.1056/NEJMra1102942.
  3. Rubin DT, Ananthakrishnan AN, Siegel CA, Sauer BG, Long MD. ACG Clinical Guideline: Ulcerative Colitis in Adults. Am J Gastroenterol. 2019 Mar;114(3):384-413. doi: 10.14309/ajg.0000000000000152.

Score Interpretation Ranges

Mild≤ pts

Mild ulcerative colitis

Moderate≤ pts

Moderate ulcerative colitis

Severe≤ pts

Severe ulcerative colitis

Need Clinical Suite Access?

Run this calculator with patient history, laboratory integration, and drug interaction safety checks on the DexaMed clinician app.

Open in Web App

Clinical Decision Support (CDS) Notice & Legal Disclaimer

This medical calculator and its scoring interpretation are provided strictly for licensed healthcare professionals and medical trainees as an educational and clinical decision support instrument. It does not replace independent clinical judgment, comprehensive patient history, physical examination, or attending physician oversight. Not FDA-cleared as an autonomous diagnostic medical device. Read the full DexaMed Medical Disclaimer.